FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Diazyme PLAC® Test for Lp-PLA2 Activity
K Number: K203136
·
Decision Aug 6, 2021
Classifications
1
FEI Numbers
1
Registration Numbers
1
Same Product Code
7
Applicant Total
11
Review Days
290
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Diazyme PLAC® Test for Lp-PLA2 Activity
- K Number
- K203136
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 866.5600
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Diazyme Laboratories, Inc.
- Date Received
- October 20, 2020
- Decision Date
- August 6, 2021
- Product Code
- NOE
- Advisory Committee
- Immunology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NOE | Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2 | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NOE), ordered by most recent decision date.
PLAC TEST FOR LP-PLA2 ACTIVITY
FDA 510(k)
FDA Class 2
·Immunology
PLAC TEST REAGENT KIT, MODELS 90107, 90112, 90115, 90116, 10-0112, 10-0113, 10-0115
FDA 510(k)
FDA Class 2
·Immunology
PLAC TEST REAGENT KIT,CALIBRATOR KIT, LP-PLA2 CONTROL KIT, MODEL(S) 90107,90109,90109
FDA 510(k)
FDA Class 2
·Immunology
MODIFICATION TO DIADEXUS PLAC TEST
FDA 510(k)
FDA Class 2
·Immunology
DIADEXUS PLAC TEST
FDA 510(k)
FDA Class 2
·Immunology
MODIFICATION TO DIADEXUS PLAC TEST
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Diazyme Laboratories, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K253069 | Lipoprotein (a) Molarity Assay | Jun 16, 2026 | Substantially Equivalent |
| K252336 | Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay | Apr 24, 2026 | Substantially Equivalent |
| K253358 | Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain Assay | Dec 19, 2025 | Substantially Equivalent |
| K243462 | Diazyme Colorimetric Lithium Assay | Aug 1, 2025 | Substantially Equivalent |
| K211648 | Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay | Sep 8, 2022 | Substantially Equivalent |
| K220001 | Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay | Aug 4, 2022 | Substantially Equivalent |
| K212221 | Diazyme DZ-Lite iFlash Total beta-hCG Assay, Diazyme DZ-Lite iFlash 1800 Chemiluminescence Immunoassay Analyzer | Dec 13, 2021 | Substantially Equivalent |
| K180209 | Diazyme 1,5-AG Assay | Oct 4, 2018 | Substantially Equivalent |
| K181438 | Diazyme Human Kappa Free Light Chain Assay; Diazyme Human Lambda Free Light Chain Assay | Jun 26, 2018 | Substantially Equivalent |
| K180074 | Diazyme Lipoprotein (a) Assay | Mar 22, 2018 | Substantially Equivalent |